Dexcom Announced Launch Of One+ CGM In UK, State Of Type 2 Report

Dexcom launches its highly customizable One+ continuous glucose monitor in the UK as well as a state of type 2 report that suggests 63% of people living with type 2 diabetes have trouble managing their disease.

Dexcom
• Source: Shutterstock

DexCom, Inc. announced on 20 May it launched continuous glucose monitor One+ in the UK following a phased launch of the device in Spain, Belgium and Poland earlier this year.

The company also published a type 2 landscape report, to coincide with the UK’s observed Type 2 Diabetes Prevention Week,...

More from United Kingdom

More from Europe

EU Life Sciences Strategy Must Address ‘Regulatory Lasagna’

 

MedTech Europe is ready to become involved and shape Europe’s Life Sciences Strategy and help drive regulatory simplification from the top to make the EU “the world’s most attractive place for life sciences by 2030.”

Questions Over UK Prevention Agenda Within NHS 10-Year Plan

 
• By 

The UK government’s blueprint to deliver an NHS "fit for the future" was released on July 3.

June 2025: A Bumper Month For New EU Medtech Documents And Initiatives

 

The rate at which new documents to support the implementation of EU medtech regulations are issued has slowed of late; but June bucked the trend, with a flurry of activity.